Irreversible Bilateral Cicatricial Keratoconjunctivitis after Dupilumab Therapy

Irreversible Bilateral Cicatricial Keratoconjunctivitis after Dupilumab Therapy

This report highlights a case of irreversible bilateral cicatricial keratoconjunctivitis related to dupilumab therapy for the treatment of severe atopic dermatitis (AD). After 38 years of AD, the patient began dupilumab therapy and achieved disease control. Two years into treatment, his ophthalmic e...

Full description

Bibliographic Details
Main Authors: Minh T. Nguyen, Mai Tsukikawa, Whitney Lomazow, Michele Lee
Format: Article
Language:English
Published: Karger Publishers 2022-08-01
Series:Case Reports in Ophthalmology
Subjects:
dupilumab
atopic dermatitis
drug reaction
cicatricial keratoconjunctivitis
symblepharon
ankyloblepharon
Online Access:https://www.karger.com/Article/FullText/525738

Internet

https://www.karger.com/Article/FullText/525738

Similar Items